Lorke D, Nurulain S, Hasan M, Kuca K, Petroianu G. Oximes as pretreatment before acute exposure to paraoxon. J Appl Toxicol. 2019;39:1506-1515 pubmed publisher

Blanco J, Gastaldi A, Gardim C, Araujo J, Simões M, Oliveira L, et al. Chronic cholinergic stimulation promotes changes in cardiovascular autonomic control in spontaneously hypertensive rats. Auton Neurosci. 2015;193:97-103 pubmed publisher

Zakirova Z, Tweed M, Crynen G, Reed J, Abdullah L, Nissanka N, et al. Gulf War agent exposure causes impairment of long-term memory formation and neuropathological changes in a mouse model of Gulf War Illness. PLoS ONE. 2015;10:e0119579 pubmed publisher

Vandeput M, Parsajoo C, Vanheuverzwijn J, Patris S, Yardim Y, le Jeune A, et al. Flow-through enzyme immobilized amperometric detector for the rapid screening of acetylcholinesterase inhibitors by flow injection analysis. J Pharm Biomed Anal. 2015;102:267-75 pubmed publisher

Smith T, Cornblath W. Alternating superior and inferior oblique myokymia. JAMA Ophthalmol. 2014;132:898-9 pubmed publisher

Ferchmin P, Andino M, Reyes Salaman R, Alves J, Velez Roman J, Cuadrado B, et al. 4R-cembranoid protects against diisopropylfluorophosphate-mediated neurodegeneration. Neurotoxicology. 2014;44:80-90 pubmed publisher

Rodrigues S, Correia A, Antunes S, Nunes B. Alterations in gills of Lepomis gibbosus, after acute exposure to several xenobiotics (pesticide, detergent and pharmaceuticals): morphometric and biochemical evaluation. Drug Chem Toxicol. 2015;38:126-32 pubmed publisher

Lataro R, Silva C, Fazan R, Rossi M, Prado C, Godinho R, et al. Increase in parasympathetic tone by pyridostigmine prevents ventricular dysfunction during the onset of heart failure. Am J Physiol Regul Integr Comp Physiol. 2013;305:R908-16 pubmed publisher

Selcen D, Shen X, Milone M, Brengman J, Ohno K, Deymeer F, et al. GFPT1-myasthenia: clinical, structural, and electrophysiologic heterogeneity. Neurology. 2013;81:370-8 pubmed publisher

Jiang L, Wu W, Guan W, Wu Z, Nie Y. Overlooked myasthenia gravis in an elderly adult. J Am Geriatr Soc. 2013;61:840-1 pubmed publisher

Spillane J, Higham E, Kullmann D. [Myasthenia gravis]. Praxis (Bern 1994). 2013;102:603-6 pubmed publisher

Aung T, Dowden A. Successful desensitization protocol for pyridostigmine hypersensitivity in a patient with myasthenia gravis. Ann Allergy Asthma Immunol. 2013;110:308 pubmed publisher

Tan Q, Jiang R, Xu M, Liu G, Li S, Zhang J. Nanosized sustained-release pyridostigmine bromide microcapsules: process optimization and evaluation of characteristics. Int J Nanomedicine. 2013;8:737-45 pubmed publisher

Finlayson S, Palace J, Belaya K, Walls T, Norwood F, Burke G, et al. Clinical features of congenital myasthenic syndrome due to mutations in DPAGT1. J Neurol Neurosurg Psychiatry. 2013;84:1119-25 pubmed publisher

Raghunath A. Gingival pain: an unusual side effect of ziprasidone. BMJ Case Rep. 2013;2013: pubmed publisher

Zach H, Cetin H, Hilger E, Paul A, Wuschitz B, Jung R, et al. The effect of early prednisolone treatment on the generalization rate in ocular myasthenia gravis. Eur J Neurol. 2013;20:708-13 pubmed publisher

Maddison P. Treatment in Lambert-Eaton myasthenic syndrome. Ann N Y Acad Sci. 2012;1275:78-84 pubmed publisher

Sabino J, da Silva C, de Melo R, Fazan R, Salgado H. The treatment with pyridostigmine improves the cardiocirculatory function in rats with chronic heart failure. Auton Neurosci. 2013;173:58-64 pubmed publisher

Tan Q, Zhang L, Zhang L, Teng Y, Zhang J. Design and evaluation of an economic taste-masked dispersible tablet of pyridostigmine bromide, a highly soluble drug with an extremely bitter taste. Chem Pharm Bull (Tokyo). 2012;60:1514-21 pubmed

Oh S, Morgan M, Lu L, Hatanaka Y, Hemmi S, Young A, et al. Different characteristic phenotypes according to antibody in myasthenia gravis. J Clin Neuromuscul Dis. 2012;14:57-65 pubmed publisher

Alaama T, Basharat P, Nicolle M. Unusual case of recurrent falls: myasthenia gravis in an elderly patient. Can Fam Physician. 2012;58:1231-2 pubmed

Wadman R, Vrancken A, van den Berg L, van der Pol W. Dysfunction of the neuromuscular junction in spinal muscular atrophy types 2 and 3. Neurology. 2012;79:2050-5 pubmed publisher

Joosen M, van der Schans M, Kuijpers W, van Helden H, Noort D. Timing of decontamination and treatment in case of percutaneous VX poisoning: a mini review. Chem Biol Interact. 2013;203:149-53 pubmed publisher

Echaniz Laguna A, Pistea C, Philippi N, Enache I, Oswald Mammosser M, De Seze J, et al. Asthma as a cause of persistent dyspnea in treated myasthenia gravis patients. Eur Neurol. 2012;68:300-3 pubmed publisher

Tan Q, Zhang L, Liu G, He D, Yin H, Wang H, et al. Novel taste-masked orally disintegrating tablets for a highly soluble drug with an extremely bitter taste: design rationale and evaluation. Drug Dev Ind Pharm. 2013;39:1364-71 pubmed publisher

Iqbal M, Connolly S, Langan Y, Redmond J. A case of Lambert-Eaton myasthenic syndrome with possible myasthenia gravis. Ir Med J. 2012;105:183-4 pubmed

Bajayo A, Bar A, Denes A, Bachar M, Kram V, Attar Namdar M, et al. Skeletal parasympathetic innervation communicates central IL-1 signals regulating bone mass accrual. Proc Natl Acad Sci U S A. 2012;109:15455-60 pubmed

Zhang L, Tan Q, Cheng X, Wang H, Hu N, Zhang J. [Preparation and quality control of pyridostigmine bromide orally disintegrating tablet]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2012;43:458-61, 477 pubmed

Dixit G, Dhingra A, Kaushal D. Vincristine induced cranial neuropathy. J Assoc Physicians India. 2012;60:56-8 pubmed

Abdullah L, Evans J, Bishop A, Reed J, Crynen G, Phillips J, et al. Lipidomic profiling of phosphocholine-containing brain lipids in mice with sensorimotor deficits and anxiety-like features after exposure to Gulf War agents. Neuromolecular Med. 2012;14:349-61 pubmed publisher

Kimpinski K, Figueroa J, Singer W, Sletten D, Iodice V, Sandroni P, et al. A prospective, 1-year follow-up study of postural tachycardia syndrome. Mayo Clin Proc. 2012;87:746-52 pubmed publisher

Bolourchian N, Rangchian M, Foroutan S. Prolonged release matrix tablet of pyridostigmine bromide: formulation and optimization using statistical methods. Pak J Pharm Sci. 2012;25:607-16 pubmed

Machado M, Rocha A, de Oliveira L, de Cuba M, de Oliveira Loss I, Castellano L, et al. Autonomic nervous system modulation affects the inflammatory immune response in mice with acute Chagas disease. Exp Physiol. 2012;97:1186-202 pubmed publisher

Bharucha A, Low P, Camilleri M, Veil E, Burton D, Kudva Y, et al. A randomised controlled study of the effect of cholinesterase inhibition on colon function in patients with diabetes mellitus and constipation. Gut. 2013;62:708-15 pubmed publisher

Challan Belval A, Tramoni G, Vedrinne J, Olagne E, Vigneron M. [The use of sugammadex in a patient with myasthenia gravis]. Ann Fr Anesth Reanim. 2012;31:569-70 pubmed publisher

Dowling J, Joubert R, Low S, Durban A, Messaddeq N, Li X, et al. Myotubular myopathy and the neuromuscular junction: a novel therapeutic approach from mouse models. Dis Model Mech. 2012;5:852-9 pubmed publisher

Moss J. Gulf War illnesses are autoimmune illnesses caused by reactive oxygen species which were caused by nerve agent prophylaxis. Med Hypotheses. 2012;79:283-4 pubmed publisher

Petroianu G, Nurulain S, Shafiullah M, Hasan M, Kuca K, Lorke D. Usefulness of administration of non-organophosphate cholinesterase inhibitors before acute exposure to organophosphates: assessment using paraoxon. J Appl Toxicol. 2013;33:894-900 pubmed publisher

Vogel J, Keating G, Buchholz B. Protein binding of isofluorophate in vivo after coexposure to multiple chemicals. Environ Health Perspect. 2002;110 Suppl 6:1031-6 pubmed